Surfactin-based nanoparticles loaded with doxorubicin to overcome multidrug resistance in cancers
Sign Up to like & getrecommendations! Published in 2018 at "International Journal of Nanomedicine"
DOI: 10.2147/ijn.s157368
Abstract: Background Multidrug resistance (MDR) is one of the major obstacles to successful cancer chemotherapy. Developing efficient strategies to reverse MDR remains a major challenge. Surfactin (SUR), a cyclic lipopeptide biosurfactant, has been found to display… read more here.
Keywords: sur nanoparticles; mcf adr; dox; multidrug resistance ... See more keywords